Thanos Panayotis K, Taintor Nicholas B, Rivera Seth N, Umegaki Hiroyuki, Ikari Hiroyuki, Roth George, Ingram Donald K, Hitzemann Robert, Fowler Joanna S, Gatley S John, Wang Gene-Jack, Volkow Nora D
Department of Medicine, Brookhaven National Laboratory, Upton, New York, USA.
Alcohol Clin Exp Res. 2004 May;28(5):720-8. doi: 10.1097/01.alc.0000125270.30501.08.
Transient overexpression of the dopamine D2 receptor (DRD2) gene in the nucleus accumbens (NAc) using an adenoviral vector has been associated with a significant decrease in alcohol intake in Sprague Dawley rats. This overexpression of DRD2 reduced alcohol consumption in a two-bottle-choice paradigm and supported the view that high levels of DRD2 may be protective against alcohol abuse.
Using a limited access (1 hr) two-bottle-choice (water versus 10% ethanol) drinking paradigm, we examined the effects of the DRD2 vector in alcohol intake in the genetically inbred alcohol-preferring (P) and -nonpreferring (NP) rats. In addition, micro-positron emission tomography imaging was used at the completion of the study to assess in vivo the chronic (7 weeks) effects of ethanol exposure on DRD2 levels between the two groups.
P rats that were treated with the DRD2 vector (in the NAc) significantly attenuated their alcohol preference (37% decrease) and intake (48% decrease), and these measures returned to pretreatment levels by day 20. A similar pattern of behavior (attenuation of ethanol drinking) was observed in NP rats. Analysis of the [C]raclopride micro-positron emission tomography data after chronic (7 weeks) exposure to ethanol revealed clear DRD2 binding differences between the P and NP rats. P rats showed 16% lower [C]raclopride specific binding in striatum than the NP rats.
These findings further support our hypothesis that high levels of DRD2 are causally associated with a reduction in alcohol consumption and may serve as a protective factor against alcoholism. That this effect was seen in P rats, which are predisposed to alcohol intake, suggests that they are protective even in those who are genetically predisposed to high alcohol intake. It is noteworthy that increasing DRD2 significantly decreased alcohol intake but did not abolish it, suggesting that high DRD2 levels may specifically interfere with the administration of large quantities of alcohol. The significantly higher DRD2 concentration in NP than P rats after 7 weeks of ethanol therefore could account for low alcohol intake.
使用腺病毒载体在伏隔核(NAc)中短暂过表达多巴胺D2受体(DRD2)基因,已被证明与斯普拉格-道利大鼠的酒精摄入量显著减少有关。DRD2的这种过表达在双瓶选择范式中减少了酒精消耗,并支持了高水平的DRD2可能对酒精滥用具有保护作用的观点。
使用限时(1小时)双瓶选择(水与10%乙醇)饮水范式,我们研究了DRD2载体对遗传近交的嗜酒(P)和非嗜酒(NP)大鼠酒精摄入量的影响。此外,在研究结束时使用微型正电子发射断层扫描成像来体内评估乙醇暴露对两组之间DRD2水平的慢性(7周)影响。
用DRD2载体(在NAc中)处理的P大鼠显著减弱了它们对酒精的确偏好(降低37%)和摄入量(降低48%),并且这些指标在第20天恢复到预处理水平。在NP大鼠中观察到类似的行为模式(乙醇饮用量减弱)。对慢性(7周)暴露于乙醇后的[C]雷氯必利微型正电子发射断层扫描数据的分析显示,P大鼠和NP大鼠之间存在明显的DRD2结合差异。P大鼠纹状体中[C]雷氯必利特异性结合比NP大鼠低16%。
这些发现进一步支持了我们的假设,即高水平的DRD2与酒精消耗减少存在因果关系,并且可能作为预防酒精中毒的保护因素。这种效应在易饮酒的P大鼠中出现,这表明即使在那些有高酒精摄入遗传倾向的个体中,它们也具有保护作用。值得注意的是,增加DRD2显著降低了酒精摄入量,但并未消除它,这表明高水平的DRD2可能特异性地干扰大量酒精的摄入。因此,乙醇处理7周后NP大鼠中DRD2浓度显著高于P大鼠,可以解释其低酒精摄入量。